AstraZeneca, after prior issues with FluMist, ramps up production in response to pandemic

Ahead of a critical flu season, AstraZeneca is upping its manufacturing efforts to deliver more FluMist doses than previously anticipated, joining the top flu vaccine manufacturers in a push to deliver about 200 million doses.